Heron Therapeutics Inc. (HRTX)
NASDAQ: HRTX
· Real-Time Price · USD
1.33
-0.02 (-1.48%)
At close: Aug 15, 2025, 3:59 PM
1.33
-0.23%
After-hours: Aug 15, 2025, 05:03 PM EDT
Heron Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 37.2M | 38.9M | 40.78M | 32.81M | 36.02M | 34.67M | 34.23M | 31.43M | 31.76M | 29.61M | 30.03M | 26.56M | 27.63M | 23.46M | 20.66M | 23.23M | 22.44M | 20.02M |
Cost of Revenue | 9.86M | 8.46M | 10.23M | 9.46M | 10.52M | 8.44M | 9.88M | 18.21M | 20.16M | 16.85M | 12.63M | 14.72M | 16.18M | 11.36M | 10.94M | 11.35M | 14.52M | 9.21M |
Gross Profit | 27.34M | 30.45M | 30.55M | 23.35M | 25.51M | 26.23M | 24.35M | 13.23M | 11.6M | 12.76M | 17.4M | 11.84M | 11.46M | 12.1M | 9.71M | 11.88M | 7.92M | 10.81M |
Operating Income | -1.64M | 3.15M | 4.17M | -4.46M | -6.45M | -4.8M | -10.22M | -24.93M | -42.4M | -33.06M | -20.36M | -41.88M | -49.5M | -62.92M | -53.54M | -51.71M | -60.47M | -52.11M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | 2.14M | n/a | 614K | n/a | 1.64M | 614K | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -2.38M | 2.63M | 3.66M | -4.85M | -9.23M | -3.16M | -10.72M | -25.01M | -42.06M | -32.77M | -19.87M | -41.91M | -56.36M | -63.89M | -54.65M | -52.41M | -61.02M | -52.61M |
Net Income | -2.38M | 2.63M | 3.66M | -4.85M | -9.23M | -3.16M | -10.72M | -25.01M | -42.06M | -32.47M | -19.87M | -41.93M | -63.22M | -64.85M | -54.65M | -52.41M | -61.02M | -52.61M |
Selling & General & Admin | 26.05M | 25.01M | 23.2M | 23.34M | 27.52M | 26.42M | 23.62M | 24.6M | 36.44M | 32.01M | 26.7M | 28.18M | 32.12M | 32.95M | 34.37M | 34.99M | 33.16M | 24.81M |
Research & Development | 2.93M | 2.28M | 3.18M | 4.46M | 4.43M | 4.61M | 10.95M | 13.56M | 17.57M | 13.82M | 11.06M | 25.55M | 28.83M | 42.07M | 28.88M | 28.59M | 35.23M | 38.12M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 344K | 295K | n/a | -26K | n/a | n/a | n/a | n/a | -546K | -500K |
Operating Expenses | 28.98M | 27.29M | 26.38M | 27.81M | 31.95M | 31.02M | 34.57M | 38.16M | 54.01M | 45.82M | 37.76M | 53.72M | 60.95M | 75.03M | 63.25M | 63.59M | 68.39M | 62.92M |
Interest Expense | 500K | 500K | 4.43M | 500K | 400K | 563K | 2.17M | 563K | 563K | n/a | 2.47M | 26K | 6.86M | 965K | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 11.57M | 12.31M | 11.06M | 10.97M | 13.61M | 11.44M | 12.33M | 12.96M | 21.2M | 21.15M | 17.77M | 18.38M | 22.94M | 23.42M | 24.49M | 25.21M | 22.25M | 15.24M |
Cost & Expenses | 38.84M | 35.75M | 36.61M | 37.27M | 42.47M | 39.47M | 44.45M | 56.36M | 74.17M | 62.68M | 50.38M | 68.44M | 77.13M | 86.38M | 74.19M | 74.94M | 82.91M | 72.13M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -295K | n/a | 26K | 6.86M | 965K | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 154.02M | 153.49M | 153.15M | 152.83M | 152.31M | 151.2M | 150.28M | 144.99M | 119.72M | 119.25M | 119.16M | 111.73M | 102.41M | 102.12M | 101.98M | 101.91M | 98.46M | 91.39M |
Shares Outstanding (Diluted) | 154.02M | 153.49M | 153.15M | 152.83M | 152.31M | 151.2M | 150.28M | 144.99M | 119.72M | 119.25M | 119.16M | 111.73M | 102.41M | 102.12M | 101.98M | 101.91M | 98.46M | 91.39M |
EPS (Basic) | -0.02 | 0.02 | 0.02 | -0.03 | -0.06 | -0.02 | -0.07 | -0.17 | -0.35 | -0.27 | -0.23 | -0.38 | -0.62 | -0.64 | -0.54 | -0.51 | -0.62 | -0.58 |
EPS (Diluted) | -0.02 | 0.02 | 0.02 | -0.03 | -0.06 | -0.02 | -0.07 | -0.17 | -0.35 | -0.27 | -0.23 | -0.38 | -0.62 | -0.64 | -0.54 | -0.51 | -0.62 | -0.58 |
EBITDA | -1.64M | 3.71M | 8.73M | -3.88M | -5.8M | -4.11M | -5.58M | -24.2M | -41.66M | -32.34M | -24.46M | -41.18M | -48.83M | -62.2M | -53.19M | -50.95M | -59.73M | -51.38M |
EBIT | -1.88M | 3.15M | 8.15M | -4.46M | -6.45M | -4.8M | -6.3M | -24.93M | -42.4M | -33.06M | -25.25M | -41.88M | -49.5M | -62.92M | -54.08M | -51.71M | -60.47M | -52.11M |
Depreciation & Amortization | 611K | 551K | 581K | 581K | 641K | 689K | 715K | 727K | 739K | 718K | 791K | 706K | 671K | 721K | 794K | 754K | 734K | 739K |